Jin Medical International
ZJYL
ZJYL was delisted on the 31st of July, 2026.
10 hedge funds and large institutions have $88.6K invested in Jin Medical International in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
11% more funds holding
Funds holding: 9 → 10 (+1)
0.01% more ownership
Funds ownership: 0.01% → 0.01% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
32% less capital invested
Capital invested by funds: $130K → $88.6K (-$40.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$34.7K |
| 2 |
Jane Street
New York
|
+$15K |
| 3 |
Renaissance Technologies
New York
|
+$11.8K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$6.47K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$3.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$11.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11K |
| 3 |
HF
HRT Financial
New York
|
-$8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$56 |
| 5 |
Morgan Stanley
New York
|
-$29 |
ZJYL Hedge Fund Activity: Q4 2025 in Review
10 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q4 2025, worth a combined $88.6K — down 32% from $130K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ZJYL positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $34.7K. The largest seller was Millennium Management, exiting entirely with an estimated $11.1K sold.
- 10 institutional investors held Jin Medical International (ZJYL) as of Q4 2025, up from 9 in Q3 2025.
- Funds reported $88.6K of Jin Medical International stock for Q4 2025, down 32% quarter-over-quarter.
- 4 funds opened new Jin Medical International positions in Q4 2025 and 3 closed out, a net change of +1 holder.
- The largest Jin Medical International buyer in Q4 2025 was Citadel Advisors, an estimated $34.7K added.
- The largest Jin Medical International seller in Q4 2025 was Millennium Management, an estimated $11.1K sold.
Based on aggregated 13F filings for Q4 2025.